Solving for Schedule III: What Rescheduling Means for Operators

Rescheduling has sparked more questions than answers, and operators are making decisions in a fog of speculation. This session cuts through the noise with a clear-eyed look at what a move to Schedule III genuinely changes for cannabis businesses, and what stays the same. The panelists will unpack the regulatory issues that hit your bottom line. They'll examine Section 280E tax implications, shifting banking access, DEA oversight, and FDA compliance requirements, with an honest assessment of timelines and open questions. Rather than chase headlines, the panelists will focus on the practical realities shaping cannabis market trends and the opportunities ahead.